# A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women

> **NCT07669077** · PHASE1 · RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 8 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nipocalimab
- **OTHER:** Breast Milk Sampling

## Key facts

- **NCT ID:** NCT07669077
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-23
- **Primary completion:** 2027-02-16
- **Final completion:** 2027-02-16
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07669077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07669077, "A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07669077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*